Track OrthoPediatrics Corp. — Monitor price, dividends, and performance in your free portfolio

Start Tracking Free

OrthoPediatrics Corp. KIDS · Stock Open OrthoPediatrics Corp. in new tab

32.35 USD
EPS
-1.42
P/B
2.49
ROE
-9.84
Beta
0.87
Target Price
30.75 USD
Loading chart...
Key Metrics
Earnings dateFeb. 25, 2027
EPS-1.42
Book Value12.99
Price to Book2.49
Debt/Equity32.67
% Insiders29.810%
Growth
Revenue Growth0.19%
Estimates
Forward P/E-42.90
Forward EPS-0.75
Target Mean Price30.75

DCF valuation

Model fair value for OrthoPediatrics Corp. (KIDS)
Result
Sign in to run the valuation for KIDS.
Assumptions
Growth– Capex– Tax– Terminal g– Cost of equity– Cost of debt–
Analyst price targets
8 analysts · consensus None · mean target 30.75 USD (low 27.00, high 38.00) · as of 15 Nov 2026
Low 27.00
Mean 30.75
High 38.00
Price 32.35
Published broker research as supplied by our market data feed, named by firm and dated; it does not identify individual analysts. Targets carry their last refresh date; rating changes can be a few days behind.

OrthoPediatrics Corp. Logo OrthoPediatrics Corp. Analysis (KIDS)

United States Health Care Official Website Stock

Is OrthoPediatrics Corp. a good investment? OrthoPediatrics Corp. (KIDS) is currently trading at 32.35 USD. Market analysts have a consensus price target of 30.75 USD. This suggests the asset is currently trading above analyst expectations.

Earnings Schedule: OrthoPediatrics Corp. is expected to release its next earnings report on Feb. 25, 2027. The market consensus estimate for Forward EPS is -0.75.

Investor FAQ

Does OrthoPediatrics Corp. pay a dividend?

No, it does not currently pay a dividend.

What asset class is OrthoPediatrics Corp.?

OrthoPediatrics Corp. is classified as a Stock. You can compare it against 2 other assets in the "Related Symbols" list on this page.

When is the next earnings date?

The next earnings date is projected to be Feb. 25, 2027. The company currently has a trailing EPS of -1.42.

Company Profile

OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity in children; and sports medicine and other products. Its products comprise PediLoc, PediPlates, cannulated screws, PediFlex nail, PediNail, PediLoc Tibia, ACL Reconstruction System, Locking Cannulated Blade, Locking Proximal Femur, Spica Tables, RESPONSE Spine, BandLoc, Pediatric Nailing Platform | Femur, Devise Rail, Orthex, The Fassier-Duval Telescopic Intramedullary System, SLIM Nail, The GAP Nail, The Free Gliding SCFE Screw System, GIRO Growth Modulation System, PNP Tibia System, ApiFix Mid-C System, Mitchell Ponseti, VerteGlideTM, and Boston Brace 3D. The company serves pediatric orthopedic market, as well as pediatric orthopedic surgeons and caregivers. OrthoPediatrics Corp. was founded in 2006 and is headquartered in Warsaw, Indiana.

Exchange Ticker
NMS (United States) KIDS
FRA (Germany) 2X7.F
Trades
No dividend information available for this instrument.
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Fundamentals

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion